Dosimetric benefits of adaptive radiation therapy for patients with stage III non-small cell lung cancer

Abstract Background Daily adaptive radiation therapy (ART) of patients with non-small cell lung cancer (NSCLC) lowers organs at risk exposure while maintaining the planning target volume (PTV) coverage. Thus, ART allows an isotoxic approach with increased doses to the PTV that could improve local tu...

Descripción completa

Detalles Bibliográficos

Autores principales:	Lea Hoppen, Gustavo R. Sarria, Chung S. Kwok, Judit Boda-Heggemann, Daniel Buergy, Michael Ehmann, Frank A. Giordano, Jens Fleckenstein
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	BMC 2023-02-01
Colección:	Radiation Oncology
Materias:	Adaptive radiation therapy stage III NSCLC Isotoxic dose-escalation Isoeffective organ at risk sparing
Acceso en línea:	https://doi.org/10.1186/s13014-023-02222-7
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!